Namwiwat Medical
Namwiwat Medical Corporation Public Company Limited manufactures and distributes medical equipment in Thailand. The company provides medical supplies, disinfection services, medical equipment maintenance services, infectious waste services, and other medical services. It also offers equipment rental and contractual construction services. The company was formerly known as Namwiwat Engineering (199… Read more
Namwiwat Medical (NAM) - Total Assets
Latest total assets as of June 2024: ฿2.34 Billion THB
Based on the latest financial reports, Namwiwat Medical (NAM) holds total assets worth ฿2.34 Billion THB as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Namwiwat Medical - Total Assets Trend (2021–2024)
This chart illustrates how Namwiwat Medical’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Namwiwat Medical - Asset Composition Analysis
Current Asset Composition (June 2024)
Namwiwat Medical's total assets of ฿2.34 Billion consist of 78.7% current assets and 21.3% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 42.4% |
| Accounts Receivable | ฿336.46 Million | 14.3% |
| Inventory | ฿353.74 Million | 15.1% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿63.99 Million | 2.7% |
| Goodwill | ฿0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Namwiwat Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Namwiwat Medical's current assets represent 78.7% of total assets in 2024, an increase from 54.8% in 2021.
- Cash Position: Cash and equivalents constituted 42.4% of total assets in 2024, up from 2.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 15.1% of total assets.
Namwiwat Medical Competitors by Total Assets
Key competitors of Namwiwat Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Namwiwat Medical - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Namwiwat Medical generates 0.47x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Namwiwat Medical generates $8.54 in net profit.
Namwiwat Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.61 | 3.32 | 3.32 |
| Quick Ratio | 4.43 | 2.31 | 2.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿1.47 Billion | ฿ 784.24 Million | ฿ 784.24 Million |
Namwiwat Medical - Advanced Valuation Insights
This section examines the relationship between Namwiwat Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.32 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 38.4% |
| Total Assets | ฿2.35 Billion |
| Market Capitalization | $8.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values Namwiwat Medical's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Namwiwat Medical's assets grew by 38.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Namwiwat Medical (2021–2024)
The table below shows the annual total assets of Namwiwat Medical from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | ฿2.35 Billion | +38.43% |
| 2023-06-30 | ฿1.70 Billion | +60.86% |
| 2022-06-30 | ฿1.06 Billion | +28.15% |
| 2021-06-30 | ฿823.40 Million | -- |